NCT07145684

Brief Summary

The clinical trial aims to assess the effectiveness of the Objectif Santé Diabète Benin (OSanDiaBé), a culturally tailored medical nutrition therapy (MNT), in enhancing diabetes management and nutrition choices. The investigators hypothesize that participants receiving OSanDiaBé will demonstrate greater improvements in dietary adherence and greater reductions in HbA1c at 6 months compared with those receiving usual care. The investigators further hypothesize that these improvements will be maintained at 12 months following the end of active intervention contact.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
64

participants targeted

Target at P50-P75 for not_applicable type-2-diabetes

Timeline
3mo left

Started Sep 2025

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress79%
Sep 2025Oct 2026

First Submitted

Initial submission to the registry

August 11, 2025

Completed
17 days until next milestone

First Posted

Study publicly available on registry

August 28, 2025

Completed
11 days until next milestone

Study Start

First participant enrolled

September 8, 2025

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2026

Last Updated

May 15, 2026

Status Verified

May 1, 2026

Enrollment Period

1.1 years

First QC Date

August 11, 2025

Last Update Submit

May 12, 2026

Conditions

Keywords

Type 2 DiabetesCultural AdaptationMedical Nutrition TherapyDietary AdherenceAfrica

Outcome Measures

Primary Outcomes (1)

  • Hemoglobin A1C (HbA1C)

    A hemoglobin A1C (HbA1C) test is a blood test that shows the average level of blood glucose over the past two to three months.

    HbA1c will be assessed at baseline, 3, 6, and 12 months.

Secondary Outcomes (8)

  • Adherence to dietary recommendations

    Dietary adherence will be assessed at baseline, 3, 6, and 12 months.

  • Weight

    Weight will be assessed at baseline, 3, 6, and 12 months.

  • Height

    Height will be assessed at baseline, 3, 6, and 12 months.

  • Body mass index

    BMI will be assessed at baseline, 3, 6, and 12 months.

  • Waist circumference

    Waist circumference will be assessed at baseline, 3, 6, and 12 months.

  • +3 more secondary outcomes

Study Arms (2)

OSanDiaBé intervention

EXPERIMENTAL

The Objectif Sante Diabète Bénin (OSanDiaBé) intervention group will participate in four individual home sessions and eight group sessions in the first six months, with no contact between months six and twelve. They will receive the OSanDiaBé resource package, which includes a workbook and an Eating Plan based on the 4-A framework of food security.

Behavioral: A culturally tailored medical nutrition therapy

Individual standard care

NO INTERVENTION

The Individual standard care arm will be a wait-list control group who will receive standard care, including blood glucose management and general lifestyle advice, and will access the OSanDiaBe program at the end of the intervention for equitable treatment.

Interventions

This MNT intervention combines evidence-based menu plans based on the 4A framework of food security with individual nutrition counseling and group diabetes education.

OSanDiaBé intervention

Eligibility Criteria

Age40 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • outpatient in one of the participating health centers
  • be aged between 40 and 65 years old,
  • have a confirmed diagnosis of T2D for a year or longer,
  • with uncontrolled diabetes (HbA1c \>7%)
  • able to read and write in French or a support who read and write in French
  • self-identify as Beninese (born in Benin or have parents from Benin),
  • willing to commit to the study and able to attend weekly meetings
  • have family member support for behavioral change
  • suitable for general diet and lifestyle advice (i.e., no complex diet needs; suitability determined by the referring healthcare provider)
  • be willing to provide informed consent to participate.

You may not qualify if:

  • being pregnant, breastfeeding or planning pregnancy,
  • participants with type 1 diabetes
  • use of medication that might affect weight loss
  • planning to travel before the end of the intervention
  • have recent cardiovascular complications (e.g., myocardial infarction, stroke, and congestive heart failure),
  • currently involved in a similar nutritional educational program (to avoid contamination bias).
  • unable to provide consent (e.g., cognitive impairment).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Abomey-Calavi

Cotonou, Littoral Department, Benin

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Officials

  • Waliou Amoussa-Hounkpatin, PhD

    Université d'Abomey-Calavi

    PRINCIPAL INVESTIGATOR
  • Edward Bedric, PhD

    University of Arizona

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

August 11, 2025

First Posted

August 28, 2025

Study Start

September 8, 2025

Primary Completion (Estimated)

October 30, 2026

Study Completion (Estimated)

October 30, 2026

Last Updated

May 15, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will share

Data obtained from this study may be shared with qualified researchers who have an academic interest in type 2 diabetes. Any data or samples provided will be coded and will not include any personal health information (PHI). Before sharing the data, the request must receive approval, and all necessary agreements (such as a material transfer agreement) must be in place.

Shared Documents
STUDY PROTOCOL, SAP, CSR
Time Frame
Data requests can be submitted starting 9 months after article publication, and the data will be made accessible for up to 24 months. Extensions will be considered on a case-by-case basis.
Access Criteria
Access to trial IPD can be requested by qualified researchers engaging in independent scientific research and will be provided following review and approval of a research proposal and Statistical Analysis Plan (SAP) and execution of a Data Sharing Agreement (DSA).

Locations